ArticleScientific reports2026
Seroprevalence and associated risk factors of Peste des petits ruminants in goats and sheep in two zones, Oromia Region, Ethiopia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Peste des Petits Ruminants (PPR) is a severe, contagious, and transboundary viral disease of goats, sheep, camels, and wild small ruminants in more than 70 countries, including Ethiopia. Hence, a cross-sectional study was conducted from September 2023 to June 2024 to assess the seroprevalence of PPR and investigate risk factors of the disease in the West Arsi and West Hararghe zones. A total of 751 serum samples were collected from 398 goats and 353 sheep of 422 flocks found in six districts of the two zones that had not a history of PPR vaccination. A hemagglutinin-based blocking enzyme-linked immunosorbent assay was used to test the serum for antibodies against PPR. A structured questionnaire survey was used to determine potential risk factors of the disease. The overall PPR seroprevalence in the West Arsi and West Hararghe zones was 9.7% at the flock level (95% CI: 7.1-12.9) and 5.9% at the animal level (95% CI: 4.4-7.8). At the species level, the seroprevalence of PPR was found to be 5.3% in goats (95% CI: 3.5-8.0) and 6.5% in sheep (95% CI: 4.4-9.6). Multivariable logistic regression analysis indicated that a geographic zone was a significant predictor of PPR infection in goats and at the flock level. Flocks in the West Hararghe Zone were 4.5 times more likely to be seropositive than those in West Arsi (95% CI: 2.0-9.8, p < 0.001). Age was a significant predictor of PPR exposure in both goats and sheep, whereas altitude was specifically a risk factor in sheep. The present study findings indicate a generally low PPR seroprevalence in both goats and sheep in the study areas. However, the disease was present in 20 out of the 26 kebeles (wards) surveyed, showing ongoing circulation. Therefore, vaccination campaigns should be expanded to cover both zones, with emphasis on West Hararghe. A further study is recommended to identify the influence of agroecology on PPR persistence and transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.